Journal of Pharmaceutical Sciences

Cover image for Vol. 103 Issue 5

Edited By: Dr. Ronald T. Borchardt

Impact Factor: 3.13

ISI Journal Citation Reports © Ranking: 2012: 18/59 (Chemistry Medicinal); 41/152 (Chemistry Multidisciplinary); 71/261 (Pharmacology & Pharmacy)

Online ISSN: 1520-6017

Recently Published Issues

See all


Article Views Since Publication Problem
Currently, the Article Views Since Publication tool does not include any downloads accrued from November 2013 to date. We are working to fix this and hope this problem to be resolved shortly. We apologize for any inconvenience caused.

2012 Impact Factor:
The Journal of Pharmaceutical Sciences2012 Impact Factor has increased to 3.13 with over 18,000 citations! Thank you to all of our authors, readers and Editorial Board members. See JPharmSci's most cited articles.


Are you an APhA Member?
APhA members need to log in to the members only area of the APhA webiste to gain unrestricted access to all JPharmSci articles. Once you have securely logged into this area of the APhA website, Wiley Online Library will recognize your member subscription and enable access. Any reader can log in to Wiley Online Library above enabling management of e-alert registrations, preferences, and other profile information, but APhA members will be recognized as subscribers only when they are logged into the members only area of

NOW AVAILABLE:Well-characterized compound database containing physiochemical and preclinical information made available by PhRMA. Visit

We have built a database that will allow users to access data on 108 compounds that have undergone preclinical and clinical development programs in 12 pharmaceutical companies. Each compound in the database is described in detail, including physical-chemical properties, preclinical absorption, permeability, metabolism, pharmacokinetics, and allometry–scaling from animals to humans–as well as human clinical data. We hope that ready access to these datasets will serve as a resource for further exploration, collaboration and elucidating of key factors that could improve clinical drug development.

NOW AVAILABLE:Free access is now available to a special virtual issue containing five Clinical Trial and Translational Medicine commentaries that were based on this set of data. These publications communicate the results of the analysis and insights gained from a concerted effort of scientists representing many pharmaceutical companies and their collaborators.

JPharmSci Database


The Giants of Pharmaceutical Sciences

The editors of the Journal of Pharmaceutical Sciences invite you to look back at Giants of Pharmaceutical Sciences virtual issue— a special collection of all dedicated issues of the journal honoring the preeminent pharmaceutical scientists in the recent history of the field.

Most Original and Most Significant Scientific Findings - Virtual Issue

Click here

We are pleased to present the April 2014 virtual issue, featuring Ijeoma Uchegbu’s comments for the paper she chose: pH-Sensitive Nanoparticles of Curcumin–Celecoxib Combination: Evaluating Drug Synergy in Ulcerative Colitis Model pages 687-696 DOI: 10.1002/jps.23828

To download the full virtual issue, click here